Answers are grounded in this paper and cite their sources.
A facile and efficient synthesis of a series of five new pyrazine‐based organometallic complexes is being reported. The complexes (2–6) have been fully characterized. Molecules 2, 3 and 6 were structurally characterized by single crystal X‐ray crystallographic analyses. Additionally, anticancer properties of these organometallic complexes have been studied against A549 human lung carcinoma cells. Biological studies suggest that complex 5 (with pendant pyridine moieties) exhibited maximal growth inhibitory cytotoxic effect even at lower concentration (nearly 0.5–1 μM) whereas the other four compounds (2, 3, 4 and 6) were non‐toxic below 1 μM concentration. Two complexes (4 and 6) were effective only at higher doses (approx 30 μM) while the remaining two organometallic complexes (2 and 3) were able to inhibit 50% cell growth at slightly lower concentration (nearly 10 μM). As far as IC50 is concerned, 5 exhibited a minimum value ranging between 3–5 μM which is comparable with cisplatin under similar conditions.
No takes yet. Share an insight, caveat, or question.
Bhowmick et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: